<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1411222899
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AZOMYCIN 250MG CAP.
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AZITHROMYCIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, hard
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        6
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        44.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01FA10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Azomycin</strong> contains the active substance azithromycin which belongs to a group of medicines called macrolide antibiotics. Antibiotics are used to treat infections caused by micro-organisms like bacteria.</p><p><strong>Azomycin</strong> is used for the treatment of certain infections caused by bacteria that are sensitive to it, such as:</p><p>-&nbsp; chest, throat or nasal infections (such as bronchitis, pneumonia, tonsillitis, sore throat (pharyngitis) and sinusitis)</p><p>-&nbsp; ear infections</p><p>-&nbsp; skin and soft tissue infections, with exception of infected burn wounds</p><p>-&nbsp; infection of the tube that carries urine from the bladder (urethra) or the neck of the womb (cervix) caused by&nbsp;<em>Chlamidia trachomatis</em>&nbsp;(bacteria)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Azomycin</strong> <strong>if</strong><strong>:</strong></p><p>-&nbsp; you are&nbsp;allergic&nbsp;to azithromycin dihydrate, erythromycin or any macrolide or ketolide antibiotic</p><p>-&nbsp; you are allergic to any of the other ingredients of this medicine (see section no. 6)</p><p><strong>Warnings and precautions</strong></p><p>If any of the situations mentioned below apply to you, you should tell your doctor or pharmacist before taking <strong>Azomycin</strong>:</p><p>-&nbsp; you have severe liver or kidney problems</p><p>-&nbsp; you have severe heart problems or problems with your heart beat such as long QT syndrome (shown on an electrocardiogram or ECG machine)</p><p>-&nbsp; your blood levels of potassium or magnesium are too low</p><p>-&nbsp; you develop signs of another infection</p><p>-&nbsp; you are taking any ergot derivatives such as ergotamine (to treat migraine) as these medicines should not be taken together with azithromycin (see section &ldquo;Taking other medicines&rdquo;)</p><p>-&nbsp; you have a certain type of muscle weakness called myasthenia gravis</p><p>-&nbsp; you have nervous (neurological) or mental (psychiatric) problems</p><p>If you are not sure if the above apply to you, talk to your doctor or pharmacist before taking <strong>Azomycin</strong>.</p><p><strong>Taking other medicines:</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription or herbal medicines. Some other medicines may influence the use of <strong>Azomycin</strong> or vice versa.</p><p>Tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>-&nbsp; antacids - used for heartburn and indigestion. <strong>Azomycin</strong> should be taken at least 1 hour before or 2 hours after the antacid.</p><p>-&nbsp; ergotamine - (used for migraine) should not be taken at the same time as serious side effects may develop (with numbness or tingling sensations in the limbs, muscle cramps, headaches, convulsions, abdominal or chest pain)</p><p>-&nbsp; warfarin or similar medicines - used to thin the blood. Azithromycin can thin the blood even more.</p><p>-&nbsp; cisapride - (used to treat stomach problems) should not be taken at the same time as this may cause severe heart problems (shown on an electro-cardiogram or ECG machine)</p><p>-&nbsp; terfenadine - (used to treat hay fever) should not be taken at the same time as this may cause severe heart problems (shown on an electro-cardiogram or ECG machine)</p><p>-&nbsp; zidovudine or nelfinavir - used to treat HIV infections. Taking nelfinavir with azithromycin may mean that you get more of the side effects listed in this leaflet</p><p>-&nbsp; rifabutin - used to treat tuberculosis (TB)</p><p>-&nbsp; quinidine - used to treat heart rhythm problems</p><p>-&nbsp; cyclosporin - used to stop your body rejecting an organ transplant. Your doctor will regularly check your blood levels of cyclosporin and may change your dose.</p><p>Tell your doctor or pharmacist if you are taking any of the following medicines. Azithromycin can make the effects of these other medicines stronger. Your doctor may change your dose:</p><p>-&nbsp; triazolam, midazolam (sedatives)</p><p>-&nbsp; alfentanil - a painkiller used e.g. during operations</p><p>-&nbsp; theophylline - used for breathing problems such as asthma and chronic obstructive pulmonary disease (COPD)</p><p>-&nbsp; digoxin - used to treat heart problems</p><p>-&nbsp; astemizol - used to treat hay fever</p><p>-&nbsp; pimozide - used to treat mental health problems.</p><p><strong>Azomycin with food and drink:</strong></p><p>This medicine can be taken with or without food.</p><p><strong>Pregnancy, breast-feeding and fertility:</strong></p><p>If you are pregnant, breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>There is insufficient information available about the use of azithromycin during pregnancy. Therefore you should not use <strong>Azomycin</strong> during pregnancy, unless explicitly advised by your doctor.</p><p>Azithromycin is partially passed through the mother&rsquo;s milk; therefore <strong>Azomycin</strong> should not be used if you are breastfeeding.</p><p><strong>Driving and using machines:</strong></p><p>There are no data available about the influence of azithromycin on the ability to drive or operate machines. However azithromycin may cause dizziness and seizures so make sure you are not affected before driving or operating machinery.</p><p><strong>Important information about some of the ingredients of </strong><strong>Azomycin</strong><strong>:</strong></p><p>This medicine contains: Lactose.</p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Adults and young people with a body weight of 45 kg or over:</strong></p><p>500mg (2 capsules) once daily during three days with a total dose of 1500mg. Your doctor may decide to prescribe the total dose of 1500mg during a period of 5 days, with 500mg (2 capsules) the first day and 250mg (one capsule) on days 2 to 5.</p><p><strong>Infections of the neck of the womb and urethra caused by <em>Chlamydia trachomatis</em>:</strong></p><p>One dose of 1000mg (4 capsules), to be taken one time.</p><p><strong>For Gonorrhoea:</strong> the recommended dose is 1g or 2g of azithromycin in combination with 250 or 500mg of ceftriaxone.</p><p><strong>Children and adolescents under 45 kg:</strong></p><p>The capsules are not recommended. Young people with a body weight of less than 45kg should use other forms of this medicine (<strong>Azomycin</strong><strong> </strong>oral suspension).</p><p><strong>Patients with kidney or liver problems:</strong></p><p>You should tell your doctor if you have kidney or liver problems as your doctor may need to alter the normal dose.</p><p><strong>Dosage for elderly:</strong></p><p>For elderly the same dosage as for adults applies.</p><p><strong>Administration:</strong> The capsules should be taken with &frac12; glass of water.</p><p><strong>If you take more Azomycin than you should:</strong></p><p>If you have taken too much <strong>Azomycin</strong>, contact your doctor, pharmacist or go to your nearest hospital at once.</p><p>Symptoms of overdose are loss of hearing, feeling sick (nausea) or being sick (vomiting) and diarrhea. In case of overdosage admission into hospital may be necessary.</p><p><strong>If you forget to take Azomycin:</strong></p><p>If you forget to take <strong>Azomycin</strong>, take your dose as soon as possible. If it is almost time for the next dose, just skip that dose and take the next one when it is due.</p><p>If in doubt, please contact your doctor or pharmacist. If you have to skip a dose, still take all of your capsules. This means that you will finish your course a day later.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p><strong>&nbsp;</strong></p><p><strong>If you stop taking Azomycin</strong></p><p>Never stop the treatment with <strong>Azomycin</strong> on your own, but first discuss this with your doctor. If the prescribed treatment is not completely finished, the infection may come back again.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>If you have any of the following symptoms of a severe allergic reaction stop taking this medicine and tell your doctor immediately or go to the casualty department at your nearest hospital:</p><p>-&nbsp; Sudden difficulty in breathing, speaking and swallowing</p><p>-&nbsp; Swelling of the lips, tongue, face and neck</p><p>-&nbsp; Extreme dizziness or collapse</p><p>-&nbsp; Severe or itchy skin rash, especially if this shows blistering and there is soreness of the eyes, mouth or genital organs.</p><p>If you experience any of the following side effects contact your doctor as soon as possible:</p><p>-&nbsp; Diarrhea that is serious, lasts a long time or has blood in it, with stomach pain or fever. This can be a sign of a serious bowel inflammation. This is something that can rarely happen after taking antibiotics</p><p>-&nbsp; Yellowing of the skin or whites of the eyes caused by liver problems</p><p>-&nbsp; Inflammation of the pancreas, which causes severe pain in the abdomen and back</p><p>-&nbsp; Increased or reduced urine output, or traces of blood in your urine</p><p>-&nbsp; Skin rash caused by sensitivity to sunlight</p><p>-&nbsp; Unusual bruising or bleeding</p><p>-&nbsp; Irregular heartbeat.</p><p>These are all serious side effects. You may need urgent medical attention. Serious side effects are uncommon (may affect up to 1 in 100 people) or the frequency cannot be estimated from the available data.</p><p>Other side effects include:</p><p><strong>Very common (may affect more than 1 in 10 people)</strong></p><p>-&nbsp; diarrhea</p><p>-&nbsp; abdominal pain</p><p>-&nbsp; feeling sick (nausea)</p><p>-&nbsp; flatulence</p><p><strong>Common (may affect up to 1 in 10 people)</strong></p><p>-&nbsp; lack of appetite (anorexia)</p><p>-&nbsp; feeling dizzy</p><p>-&nbsp; headache</p><p>-&nbsp; sensation of pins and needles or numbness (paraesthesia)</p><p>-&nbsp; changes in your sense of taste and smell</p><p>-&nbsp; visual impairment</p><p>-&nbsp; deafness</p><p>-&nbsp; being sick (vomiting), stomach pain or cramps, loss of appetite, problems digesting your food</p><p>-&nbsp; skin rashes and itching</p><p>-&nbsp; joint pain (arthralgia)</p><p>-&nbsp; fatigue</p><p>-&nbsp; change in the quantity of the white blood cells and the concentration of bicarbonate in the blood</p><p><strong>Uncommon (may affect up to 1 in 100 people)</strong></p><p>-&nbsp; thrush (candidiasis) - a fungal infecion</p><p>-&nbsp; inflammation inside your vagina (vaginitis)</p><p>-&nbsp; reduction in the number of white blood cells</p><p>-&nbsp; angioedema</p><p>-&nbsp; hypersensitivity</p><p>-&nbsp; nervousness</p><p>-&nbsp; reduced sense of touch (hypoaesthesia)</p><p>-&nbsp; feeling drowsy (somnolence)</p><p>-&nbsp; having difficulty sleeping (insomnia)</p><p>-&nbsp; hearing loss or ringing in your ears</p><p>-&nbsp; palpitations</p><p>-&nbsp; inflammation of the lining of the stomach (gastritis)</p><p>-&nbsp; constipation</p><p>-&nbsp; liver problems such as hepatitis</p><p>-&nbsp; allergic skin reactions such as being sensitive to sunlight, red, flaking and swollen skin</p><p>-&nbsp; urticaria</p><p>-&nbsp; chest pain</p><p>-&nbsp; swelling (oedema)</p><p>-&nbsp; malaise</p><p>-&nbsp; weakness</p><p>-&nbsp; change in liver enzyme levels and blood levels</p><p><strong>Rare (may affect up to 1 in 1,000 people)</strong></p><p>-&nbsp; feeling agitated, feeling of unreality to the self and own feeling</p><p>-&nbsp; spinning sensation (vertigo)</p><p>-&nbsp; abnormal hepatic function</p><p>-&nbsp; allergic skin reactions</p><p>-&nbsp; kidney problems</p><p><strong>Not known (frequency cannot be estimated from the available data)</strong></p><p>-&nbsp; gut (colon) infection (pseudomembranous colitis)</p><p>-&nbsp; reduced number of red blood cells due to destruction (haemolytic anaemia); reduction in number of platelets</p><p>-&nbsp; anaphylactic reaction</p><p>-&nbsp; feeling angry, aggressive</p><p>-&nbsp; fainting (syncope)</p><p>-&nbsp; fits (convulsions)</p><p>-&nbsp; feeling hyperactive</p><p>-&nbsp; change in your sense of smell (anosmia, parosmia)</p><p>-&nbsp; change in your sense of taste (ageusia)</p><p>-&nbsp; exacerbation or aggravation of muscle weakness (myasthenia gravis)</p><p>-&nbsp; rapid (ventricular tachycardia) or irregular heartbeat, sometimes being life-threatening, changes of the heart rhythm found by an electro-cardiogram (QT prolongation and torsade de pointes).</p><p>-&nbsp; low blood pressure</p><p>-&nbsp; inflammation of the pancreas (pancreatitis)</p><p>-&nbsp; your tongue and teeth changes colour</p><p>-&nbsp; allergic skin reactions</p><p><strong>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</strong></p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>: </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Center (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222,</p><p>&nbsp;<strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Store below 30&deg;C, in a dry place.</p><p>-&nbsp; Do not use <strong>Azomycin</strong> after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp; Do not use <strong>Azomycin</strong> if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed off via wastewater or household waste. Ask your pharmacist how to dispose off medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Azithromycin. Each capsule contains: Azithromycin dihydrate equivalent to azithromycin 250mg.</p><p>Other ingredients: Starch, magnesium stearate, sodium lauryl sulphate, lactose, and hard gelatin shell.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Azomycin are available in packs of 6 capsules each (one blister only) and packs of 60 capsules. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                10/12/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>تحتوي كبسولات <strong>أزومايسين </strong>على المادة الفعالة أزيثرومايسين والتي تنتمي إلى مجموعة الأدوية المعروفة بالمضادات الحيوية من مجموعة الماكروليد. تستخدم المضادات الحيوية لعلاج حالات العدوى التي تسببها الكائنات الدقيقة مثل البكتيريا.</p><p>يستخدم <strong>أزومايسين</strong> في علاج بعض أنواع العدوى التي تسببها سلالات البكتيريا الحساسة له، بالمثل:</p><p>-&nbsp;&nbsp; العدوى التي تصيب الصدر، الحلق أو الأنف (بالمثل التهاب الشعب الهوائية، الالتهاب الرئوي، التهاب اللوزتين، التهاب الحلق والتهاب الجيوب الأنفية)</p><p>-&nbsp;&nbsp; العدوى التي تصيب الأذن</p><p>-&nbsp;&nbsp; العدوى التي تصيب الجلد والأنسجة الرخوة، باستثناء الحروق المصحوبة بعدوى</p><p>-&nbsp;&nbsp; العدوى التي تصيب الأنبوب الناقل للبول من المثانه (الإحليل) أو عنق الرحم والتي تسببها كلاميديا تراكوماتس (أحد أنواع البكتيريا)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>يجب عدم تناول أزومايسين في الحالات التالية:</strong></p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحساسية تجاه أزيثرومايسين ثنائي الهيدرات، إريثرومايسين، أو لأي من المضادات الحيوية من مجموعة الماكروليد أو كيتوليد</p><p>-&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من الحساسية تجاه أي من المواد غير الفعالة الأخرى في هذا الدواء ( انظر البند رقم 6).</p><p><strong>تحذيرات واحتياطات:</strong></p><p>إذا كانت أي من الحالات المذكورة أدناه تنطبق عليك، فيجب عليك إخبار طبيبك أو الصيدلي الذي تتعامل معه قبل تناول <strong>أزومايسين</strong>:</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل شديدة في الكبد أو الكلى</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في القلب أو مشاكل في نظم ضربات القلب بالمثل متلازمة طول فترة كيو تي (تظهر في الرسم البياني لتخطيط القلب أو جهاز تخطيط كهربية القلب)</p><p>-&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من انخفاض شديد لمستويات المغنيسيوم والبوتاسيوم في الدم</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ظهور علامات تشير إلى حدوث إصابة بعدوى أخرى</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تتناول أي من مشتقات الإرجوت بالمثل الإرجوتامين (دواء يستخدم لعلاج الصداع النصفي) حيث يجب عدم تناول هذه الأدوية بالتزامن مع أزيثرومايسين (انظر فقرة &quot;تناول الأدوية الأخرى&quot;)</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من إحدى أنواع داء ضعف العضلات والذي يعرف باسم الوهن العضلي الوبيل</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل عصبية أو عقلية (نفسية).</p><p>إذا كنت تعتقد أن أي من هذه الحالات تنطبق عليك أو إذا كان لديك أدنى شك بذلك، استشر طبيبك أو الصيدلي الذي تتعامل معه قبل تناول<strong> </strong><strong>أزومايسين</strong>.</p><p><strong>تناول الأدوية الأخرى:</strong></p><p>يرجى منك إخبار طبيبك أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخراًَ أية أدوية أخرى، بما في ذلك الأدوية التي تصرف بدون وصفة طبية أو الأدوية العشبية. قد تؤثر بعض الأدوية الأخرى على استخدام <strong>أزومايسين</strong> أو العكس بالعكس.</p><p>يجب عليك إخبار طبيبك أو الصيدلي الذي تتعامل معه إذا كنت تتناول أي من الأدوية التالية:</p><p>-&nbsp;&nbsp;&nbsp; مضادات الحموضة - أدوية تستخدم لعلاج حرقة الفؤاد وعسر الهضم. يجب تناول <strong>أزومايسين</strong> على الأقل قبل تناول مضادات الحموضة بساعة واحدة أو بعد مرور ساعتين من تناولها.</p><p>-&nbsp;&nbsp;&nbsp; الإرجوتامين - (دواء يستخدم لعلاج الصداع النصفي)، يجب عدم تناوله بالتزامن مع أزيثرومايسين في نفس الوقت، حيث قد يؤدي ذلك إلى حدوث تأثيرات جانبية خطيرة (مع شعور بالخدر أو الوخز في الأطراف، تقلصات عضلية، صداع، اختلاجات، آلام في البطن أو الصدر).</p><p>-&nbsp;&nbsp;&nbsp; الوارفارين أو الأدوية المشابهه له - &nbsp;دواء يستخدم لترقيق &nbsp;الدم ومنع التخثر. قد يزيد أزيثرومايسين من سيولة الدم.</p><p>-&nbsp;&nbsp;&nbsp; سيسابريد - (دواء يستخدم لعلاج مشاكل المعدة) يجب عدم إعطائه في نفس الوقت مع أزيثرومايسين حيث قد يتسبب ذلك في حدوث مشاكل شديدة في القلب (تظهر في الرسم البياني لتخطيط القلب أو جهاز تخطيط كهربية القلب)</p><p>-&nbsp;&nbsp;&nbsp; تيرفينادين - (دواء يستخدم لعلاج حمى القش) يجب عدم تناوله بالتزامن مع أزيثرومايسين حيث قد يتسبب ذلك في حدوث مشاكل شديدة في القلب (تظهر في الرسم البياني لتخطيط القلب أو جهاز تخطيط كهربية القلب)</p><p>-&nbsp;&nbsp;&nbsp; زيدوفيودين أو نيلفينافير- أدوية تستخدم لعلاج عدوى فيروس نقص المناعة البشرية. إن تناول نيلفينافير بالتزامن مع أزيثرومايسين قد يؤدي إلى حدوث الكثير من التأثيرات الجانبية المذكورة في هذه النشرة.</p><p>-&nbsp;&nbsp;&nbsp; ريفابيوتين - دواء يستخدم لعلاج السل الرئوي</p><p>-&nbsp;&nbsp;&nbsp; كوينيدين - دواء يستخدم لعلاج مشاكل نظم ضربات القلب</p><p>-&nbsp;&nbsp;&nbsp; سايكلوسبورين - دواء يستخدم لمنع الجسم من رفض الأعضاء المزروعة. سيقوم الطبيب بإجراء فحص منتظم لقياس مستويات السايكلوسبورين في الدم، وقد يقوم بتغيير مقدار الجرعة التي تتناولها.</p><p>يرجى منك إخبار طبيبك أو الصيدلي الذي تتعامل معه إذا كنت تتناول أي من الأدوية التالية، حيث أن أزيثرومايسين قد يعمل على جعل فعالية تلك الأدوية أكثر قوة، مما قد يدفع الطبيب إلى تغيير مقدار الجرعة التي تتناولها:</p><p>-&nbsp;&nbsp;&nbsp; ترايازولام، ميدازولام (أدوية مهدئة)</p><p>-&nbsp;&nbsp;&nbsp; ألفينتانيل- دواء مسكن للألم يستخدم على سبيل المثال أثناء العمليات</p><p>-&nbsp;&nbsp;&nbsp; ثيوفيلين - دواء يستخدم لعلاج مشاكل التنفس بالمثل الربو ومرض الإنسداد الرئوي المزمن</p><p>-&nbsp;&nbsp;&nbsp; ديجوكسين- دواء يستخدم لعلاج مشاكل القلب</p><p>-&nbsp;&nbsp;&nbsp; أستيميزول - دواء يستخدم لعلاج حمى القش</p><p>-&nbsp;&nbsp;&nbsp; بيموزيد - دواء يستخدم لعلاج المشاكل النفسية</p><p><strong>تناول أزومايسين مع الطعام والشراب:</strong></p><p>يمكن تناول هذا الدواء مع أو بدون الطعام.</p><p><strong>الحمل، الرضاعة والخصوبة:</strong></p><p>إذا كنت حاملاً أو مرضعاً أو لديك شك بأنك حامل أو تخططين لتصبحي حاملاً، يجب عليك استشارة طبيبك أو الصيدلي الذي تتعاملين معه قبل تناول هذا الدواء.</p><p>لا تتوافر أية معلومات كافية حول استخدام أزيثرومايسين خلال فترة الحمل، لذا يجب عليك عدم استخدام <strong>أزومايسين</strong> خلال فترة الحمل ما لم ينصحك الطبيب باستخدامه.</p><p>يعبر أزيثرومايسين بصورة جزئية إلى حليب الأم، لذا يجب عليك عدم استخدام <strong>أزومايسين</strong> إذا كنت مرضعاً.</p><p><strong>القيادة واستخدام الآلات:</strong></p><p>لا تتوافر أية بيانات حول مدى تأثير أزيثرومايسين على القدرة على القيادة أو تشغيل الآلات ولكن مع ذلك قد يتسبب أزيثرومايسين في حدوث دوخة وتشنجات، لذا يجب عليك التأكد من عدم التعرض لمثل هذه التأثيرات قبل القيام بالقيادة أو تشغيل الآلات.</p><p><strong>معلومات هامة عن بعض مكونات أزومايسين:</strong></p><p>يحتوي هذا الدواء على: لاكتوز.</p><p>استشر طبيبك قبل تناول هذا الدواء إذا كان قد اخبرك مسبقاً بأنك تعاني من مشكلة تتمثل في عدم المقدرة على تحمل بعض أنواع السكر.</p><p><strong>&nbsp;&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يجب استخدام هذا الدواء دائماً بدقة وفقاً لتعليمات الطبيب. استشر طبيبك أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من طريقة الاستخدام.</p><p><strong>الكبار والبالغون بوزن 45 كلغم أو أكثر:</strong></p><p>يتم تناول 500 ملغم (كبسولتان) مرة واحدة يومياً لمدة 3 أيام، بحيث يصبح المقدار الكلي للجرعة خلال الدورة العلاجية 1500 ملغم.</p><p>قد يقرر الطبيب إعطائك المقدار الكلي للجرعة 1500 ملغم على مدار 5 أيام، بحيث يتم تناول 500 ملغم (كبسولتان) في اليوم الأول و250 ملغم (كبسولة واحدة) في اليوم الثاني إلى اليوم الخامس من الدورة العلاجية.</p><p><strong>الالتهابات التي تصيب عنق الرحم أو الإحليل والتي تسببها كلاميديا تراكوماتس:</strong></p><p>يتم تناول 1000 ملغم (4 كبسولات) كجرعة مفردة مرة واحدة.</p><p><strong>علاج داء السيلان:</strong></p><p>يبلغ مقدار الجرعة الموصى بها 1 غرام أو 2غرام من أزيثرومايسين بالإضافة إلى سيفترايكسون بجرعة مقدارها 250 أو 500 ملغم</p><p><strong>الأطفال والبالغون بوزن أقل من 45 كلغم:</strong></p><p>لا يوصى بإعطاء الكبسولات لهذه الفئة من المرضى.</p><p>يجب استخدام الأشكال الدوائية الأخرى المتوفرة من هذا الدواء (<strong>أزومايسين</strong> معلق فموي) لهذه الفئة من المرضى.</p><p><strong>المرضى الذين يعانون من مشاكل في الكلى أو الكبد:</strong></p><p>إذا كنت تعاني من مشاكل في الكلى أو الكبد، فيجب عليك إخبار طبيبك بذلك فقد يستلزم الأمر إجراء تغيير لمقدار الجرعة المعتادة التي تتناولها.</p><p><strong>الجرعة للمرضى كبار السن:</strong></p><p>يتم استخدام نفس الجرعة الموصى بها للبالغون.</p><p><strong>كيفية تناول هذا الدواء: </strong>يجب تناول الكبسولات مع نصف كوب من الماء.</p><p><strong>إذا تناولت </strong><strong>أزومايسين</strong><strong> بجرعة أكبر من الاعتيادية على سبيل الخطأ:</strong></p><p>إذا كنت قد تناولت <strong>أزومايسين</strong> بجرعات أكبر مما ينبغي عليك تناولها، اتصل بطبيبك أو الصيدلي الذي تتعامل معه أو توجه إلى أقرب مستشفى في الحال.</p><p>تتضمن أعراض فرط الجرعة فقدان السمع، الإعياء(غثيان أو تقيؤ) وإسهال. في حالة فرط الجرعة قد يكون من الضروري إدخال المريض إلى المستشفى.</p><p><strong>إذا سهوت عن تناول أزومايسين:</strong></p><p>إذا سهوت عن تناول جرعة من <strong>أزومايسين</strong> فيجب عليك تناول هذه الجرعة في أسرع&nbsp; وقت ممكن حال تذكرها، ولكن إذا كان موعد الجرعة التالية قد اقترب، فيستحسن الاستمرار في جدول الجرعات دون أخذ الجرعة التي سهوت عنها.</p><p>إذا كان لديك أدنى شك بذلك اتصل بطبيبك أو الصيدلي الذي تتعامل معه.</p><p>&nbsp;</p><p>يجب عليك تناول جميع الكبسولات الموجودة في العبوة حتى وإن تطلب الأمر في بعض الأحيان عدم تناول جرعة ما، وهذا يعنى أن الدورة العلاجية الموصوفة لك سوف تمتد ليوم إضافي آخر.</p><p>لا تتناول جرعة مضاعفة لتعويض الجرعات المفردة التي قد سهوت عن تناولها.</p><p><strong>إذا توقفت عن تناول أزومايسين</strong></p><p>لا توقف العلاج باستخدام <strong>أزومايسين</strong> من تلقاء نفسك، ولكن يجب أولاً مناقشة هذا الأمر مع طبيبك المعالج. فقد تعود العدوى بالظهور مرة أخرى إذا لم تقم بإكمال الدورة العلاجية كما وصفت لك.</p><p><strong>إذا كانت لديك مزيد من الاستفسارات التي تخص استعمال هذا الدواء، اتصل بطبيبك أو الصيدلي الذي تتعامل معه.</strong></p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء، إلى حدوث تأثيرات جانبية، ولكنها قد لا تحدث لكل شخص.</p><p>إذا كنت تعاني من حدوث أي من الأعراض التالية للتفاعلات التحسسية الشديدة توقف عن تناول هذا الدواء واخبر طبيبك على الفور أو توجه إلى قسم الطوارئ بأقرب مستشفى:<strong> </strong></p><p>-&nbsp;&nbsp;&nbsp; صعوبة مفاجأة في التنفس، الكلام والبلع</p><p>-&nbsp;&nbsp;&nbsp; تورم الشفتين، اللسان، الوجه والرقبة</p><p>-&nbsp;&nbsp;&nbsp; دوخة شديدة أو إغماء</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي شديد أو مصحوب بحكة، وخاصة إذا كان مصحوباً بظهور بثور وكذلك عند الشعور بحرقة في العينين، الفم أو الأعضاء التناسلية.</p><p>في حال تعرضك لأي من التأثيرات الجانبية التالية، اتصل بطبيبك في أقرب وقت ممكن:</p><p>-&nbsp;&nbsp;&nbsp; إسهال خطير يستمر لفترة طويلة أو يحتوي على آثار للدماء يصاحبه آلام في المعدة أو حمى. قد يكون ذلك علامة على وجود التهاب خطير في الأمعاء. نادراً ما قد يحدث ذلك عقب تناول إحدى المضادات الحيوية.</p><p>-&nbsp;&nbsp;&nbsp; اصفرار الجلد أو بياض العينين الناجم عن وجود مشاكل في الكبد.</p><p>-&nbsp;&nbsp;&nbsp; التهاب البنكرياس، والذي يسبب آلام شديدة في البطن والظهر.</p><p>-&nbsp;&nbsp;&nbsp; زيادة أو انخفاض كمية البول المطروحة خارج الجسم أو وجود آثار للدماء في البول.</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي ناجم عن الحساسية تجاه أشعة الشمس.</p><p>-&nbsp;&nbsp;&nbsp; حدوث الكدمات أو النزيف بصورة غير معتادة.</p><p>-&nbsp;&nbsp;&nbsp; عدم انتظام ضربات القلب.</p><p>تعد جميع هذه التأثيرات الجانبية خطيرة وفي حال حدوثها قد يتطلب الأمر الخضوع للعناية الطبية العاجلة. كما أنها تعد غير شائعة (قد تصيب ما يصل إلى شخص واحد لكل 100 من الأشخاص) أو لا يمكن تقدير عدد مرات حدوثها من البيانات المتاحة.</p><p>تتضمن التأثيرات الجانبية الأخرى:</p><p><strong>شائعة جداً (قد تصيب أكثر من شخص لكل 10 من الأشخاص)</strong></p><p>-&nbsp;&nbsp;&nbsp; إسهال</p><p>-&nbsp;&nbsp;&nbsp; ألم في البطن</p><p>-&nbsp;&nbsp;&nbsp; شعور بالإعياء (غثيان)</p><p>-&nbsp;&nbsp;&nbsp; انتفاخ</p><p><strong>شائعة (قد تصيب ما يصل إلى شخص واحد لكل 10 من الأشخاص)</strong></p><p>-&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p>-&nbsp;&nbsp;&nbsp; شعور بالدوخة</p><p>-&nbsp;&nbsp;&nbsp; صداع</p><p>-&nbsp;&nbsp;&nbsp; شعور بالوخز أو الخدر</p><p>-&nbsp;&nbsp;&nbsp; اضطرابات في حاسة التذوق والشم</p><p>-&nbsp;&nbsp;&nbsp; ضعف البصر</p><p>-&nbsp;&nbsp;&nbsp; الصمم</p><p>-&nbsp;&nbsp;&nbsp; الإعياء (قيء)، ألم في المعدة أو تقلصات، فقدان الشهية، مشاكل في هضم الطعام</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي وحكة</p><p>-&nbsp;&nbsp;&nbsp; آلام المفاصل</p><p>-&nbsp;&nbsp;&nbsp; شعور بالتعب</p><p>-&nbsp;&nbsp;&nbsp; تغير في عدد كريات الدم البيضاء وتركيز البيكربونات في الدم</p><p><strong>غير شائعة (قد تصيب ما يصل إلى شخص واحد لكل 100 من الأشخاص)</strong></p><p>-&nbsp;&nbsp;&nbsp; مرض القلاع (داء المبيضات)- وهوعبارة عن عدوى فطرية</p><p>-&nbsp;&nbsp;&nbsp; التهابات داخل المهبل (التهابات مهبلية)</p><p>-&nbsp;&nbsp;&nbsp; نقص عدد كريات الدم البيضاء</p><p>-&nbsp;&nbsp;&nbsp; وذمة وعائية</p><p>-&nbsp;&nbsp;&nbsp; فرط الحساسية</p><p>-&nbsp;&nbsp;&nbsp; العصبية</p><p>-&nbsp;&nbsp;&nbsp; ضعف حاسة اللمس</p><p>-&nbsp;&nbsp;&nbsp; شعور بالنعاس</p><p>-&nbsp;&nbsp;&nbsp; صعوبة في النوم (أرق)</p><p>-&nbsp;&nbsp;&nbsp; فقدان السمع أو رنين في الأذنين</p><p>-&nbsp;&nbsp;&nbsp; خفقان</p><p>-&nbsp;&nbsp;&nbsp; التهاب بطانة المعدة (التهاب المعدة)</p><p>-&nbsp;&nbsp;&nbsp; إمساك</p><p>-&nbsp;&nbsp;&nbsp; مشاكل في الكبد بالمثل التهاب الكبد</p><p>-&nbsp;&nbsp;&nbsp; تفاعلات تحسسية جلدية بالمثل الحساسية تجاه أشعة الشمس، احمرار، تقشر وانتفاخ الجلد</p><p>-&nbsp;&nbsp;&nbsp; شرى</p><p>-&nbsp;&nbsp;&nbsp; ألم في الصدر</p><p>-&nbsp;&nbsp;&nbsp; تورم (وذمة)</p><p>-&nbsp;&nbsp;&nbsp; شعور بالضيق</p><p>-&nbsp;&nbsp;&nbsp; شعور بالضعف</p><p>-&nbsp;&nbsp;&nbsp; تغير في مستويات انزيمات الكبد ومستويات الدم</p><p><strong>نادرة (</strong><strong>قد تصيب ما يصل إلى شخص واحد لكل 1000 من الأشخاص</strong><strong>)</strong></p><p>-&nbsp;&nbsp;&nbsp; شعور بالهياج والتوهان</p><p>-&nbsp;&nbsp;&nbsp; شعور بالدوار</p><p>-&nbsp;&nbsp;&nbsp; اضطراب في وظائف الكبد</p><p>-&nbsp;&nbsp;&nbsp; تفاعلات تحسسية جلدية</p><p>-&nbsp;&nbsp;&nbsp; مشاكل في الكلى</p><p><strong>غير معروفة (لا يمكن تقدير </strong><strong>عدد مرات حدوثها من البيانات المتاحة</strong><strong>)</strong></p><p>-&nbsp;&nbsp;&nbsp; التهاب القولون (التهاب القولون الغشائي الكاذب)</p><p>-&nbsp;&nbsp;&nbsp; نقص في عدد خلايا الدم الحمراء ناتج عن تحللها (فقر الدم الانحلالي)، نقص عدد الصفيحات الدموية</p><p>-&nbsp;&nbsp;&nbsp; تفاعلات استهدافية</p><p>-&nbsp;&nbsp;&nbsp; شعور بالغضب والعدوانية</p><p>-&nbsp;&nbsp;&nbsp; إغماء</p><p>-&nbsp;&nbsp;&nbsp; تشنجات</p><p>-&nbsp;&nbsp;&nbsp; شعور بفرط النشاط</p><p>-&nbsp;&nbsp;&nbsp; اضطرابات في حاسة الشم (فقدان حاسة الشم، اضطرابات في حاسة الشم)</p><p>-&nbsp;&nbsp;&nbsp; اضطرابات في حاسة التذوق (فقدان حاسة التذوق)</p><p>-&nbsp;&nbsp;&nbsp; تفاقم داء ضعف العضلات (الوهن العضلي الوبيل)</p><p>-&nbsp;&nbsp;&nbsp; تسارع (تسارع ضربات القلب البطينية) أو عدم انتظام ضربات القلب، والتي قد تكون في بعض الأحيان مهددة للحياة، حدوث تغييرات في نظم ضربات القلب يتم الكشف عنها عن طريق الرسم البياني لتخطيط القلب (إطالة فترة كيو تي وتورساد دي بوينت)</p><p>-&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم</p><p>-&nbsp;&nbsp;&nbsp; التهاب البنكرياس</p><p>-&nbsp;&nbsp;&nbsp; تغير لون اللسان والأسنان</p><p>-&nbsp;&nbsp;&nbsp; تفاعلات تحسسية جلدية</p><p><strong>في </strong><strong>حال تعرضك لأية تأثيرات جانبية بما في ذلك أية </strong><strong>تأثيرات جانبية أخرى يحتمل حدوثها ولم تذكر في هذه النشرة، يرجى إخبار طبيبك أو الصيدلي الذي تتعامل معه.</strong></p><p><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong><br /><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p><strong>رقم الفاكس: </strong>7662-205-11-966+</p><p><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على: </strong>2038222-11-966+ <strong>تحويلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p><strong>الهاتف المجاني: </strong>8002490000</p><p><strong>البريد الإلكتروني:</strong><strong> </strong>&nbsp;npc.drug@sfda.gov.sa</p><p><strong>الموقع الإلكتروني:</strong> www.sfda.gov.sa/npc</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p>-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&ordm;م، في مكان جاف.</p><p>-&nbsp;&nbsp;&nbsp; لا تستخدم <strong>أزومايسين</strong> بعد انتهاء تاريخ الصلاحية المذكور على العبوة والشريط.</p><p>-&nbsp;&nbsp;&nbsp; لا تستخدم <strong>أزومايسين</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي أزيثرومايسين. تحتوي كل كبسولة على: أزيثرومايسين ثنائي الهيدرات بما يعادل 250 ملغم من أزيثرومايسين.</p><p>المواد الأخرى: نشا الذرة، استيارات المغنيسيوم، لوريل كبريتات الصوديوم، لاكتوز وغلاف من الجيلاتين الصلب.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            يتوفر أزومايسين في عبوات تحتوي كل منها على 6 كبسولات (شريط واحد فقط) وعبوات تحتوي على 60 كبسولة.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>&quot;الخليج للصناعات الدوائية &quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            10-12-2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Azomycin 250mg Capsules 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains:
Item No.	Material Name	Scale (mg/Capsule)
		
	Active Ingredient:	
1.		Azithromycin 	250.000
	Equivalent to Azithromycin Dihydrate	262.000
		
	Inactive Ingredients:	
1.		Maize starch 	50.000
2.		Sodium lauryl sulphate 	1.000
3.		Magnesium stearate 	10.000
4.		Lactose anhydrous 	q.s. to 520.000*
5.		Empty hard gelatin capsule shell size “0”	1 no.

* Quantity of Lactose Anhydrous may vary to accommodate the quantity of Azithromycin Dihydrate to adjust the potency.

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hard gelatin Capsules.
Description: Hard gelatin capsule, shell size “0” with red opaque cap and pink opaque body, filled with white to almost white crystalline powder.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Azomycin</strong> is indicated for the following bacterial infections induced by micro-organisms susceptible to azithromycin (see sections 4.4 and 5.1):</p><p>&sect; Acute bacterial sinusitis (adequately diagnosed)</p><p>&sect; Acute bacterial otitis media (adequately diagnosed)</p><p>&sect; Pharyngitis, tonsillitis</p><p>&sect; Acute exacerbation of chronic bronchitis (adequately diagnosed)</p><p>&sect; Mild to moderately severe community acquired pneumonia</p><p>&sect; Infections of the skin and soft tissues of mild to moderate severity e.g. folliculitis, cellulitis, erysipelas</p><p>&sect; Uncomplicated Chlamydia trachomatis urethritis and cervicitis</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Azomycin </strong>should be given as a single daily dose. Duration of the treatment for the different infection diseases is given below.</p><p>The capsules can be taken with or without food.</p><p>The capsules should be taken with &frac12; glass of water.</p><p><strong><em>Children and adolescents with a body weight above 45 kg, adults and the elderly:</em></strong></p><p>The total dose is 1500 mg, administered as 500 mg once daily for 3 days. Alternatively, the same total dose (1500 mg) can be administered in a period of 5 days, 500 mg on the first day and 250 mg on day 2 to 5.</p><p>In the case of uncomplicated&nbsp;<em>Chlamydia trachomatis</em>&nbsp;urethritis and cervicitis, the dosage is 1000 mg as a single oral dose.</p><p><strong><em>Children and adolescents with a body weight below 45 kg:</em></strong></p><p>Azithromycin capsules are not suitable for patients under 45 kg body weight. Other dosage forms are available for this group of patients.</p><p><strong><em>Elderly patients</em></strong></p><p>For elderly patients the same dose as for adults can be applied. Since elderly patients can be patients with ongoing proarrhythmic conditions a particular caution is recommended due to the risk of developing cardiac arrhythmia and torsades de pointes. (see section 4.4).</p><p><strong><em>Patients with renal impairment:</em></strong></p><p>Dose adjustment is not required in patients with mild to moderate renal impairment (GFR 10-80 ml/min) (see section 4.4).</p><p><strong><em>Patients with hepatic impairment:</em></strong></p><p>Dose adjustment is not required for patients with mild to moderate hepatic dysfunction (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The use of this product is contraindicated in patients with hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide antibiotic, or to any of the excipient listed in section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with erythromycin and other macrolides, rare serious allergic reactions including angioneurotic oedema and anaphylaxis (rarely fatal), have been reported. Some of these reactions with azithromycin have resulted in recurrent symptoms and required a longer period of observation and treatment.</p><p>Since the liver is the principal route of elimination for azithromycin, the use of azithromycin should be undertaken with caution in patients with significant hepatic disease. Cases of fulminant hepatitis potentially leading to life-threatening liver failure have been reported with azithromycin (see section 4.8). Some patients may have had pre-existing hepatic disease or may have been taking other hepatotoxic medicinal products.</p><p>In case of signs and symptoms of liver dysfunction, such as rapid developing asthenia associated with jaundice, dark urine, bleeding tendency or hepatic encephalopathy, liver function tests/ investigations should be performed immediately. Azithromycin administration should be stopped if liver dysfunction has emerged.</p><p>In patients receiving ergot derivatives, ergotism has been precipitated by coadministration of some macrolide antibiotics. There are no data concerning the possibility of an interaction between ergotamine derivatives and azithromycin. However, because of the theoretical possibility of ergotism, azithromycin and ergot derivatives should not be co-administered (see section 4.5).</p><p><em>Superinfections:</em></p><p>As with any antibiotic preparation, it is recommended to pay attention to signs of superinfection with non-susceptible micro-organisms like fungi. A superinfection may require an interruption of the azithromycin treatment and initiation of adequate measures.</p><p><em>Clostridium difficile</em>&nbsp;associated diarrhoea (CDAD) has been reported with use of nearly all antibacterial agents, including azithromycin, and may range in severity from mild diarrhoea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of&nbsp;<em>C. difficile</em>.</p><p><em>C. difficile</em>&nbsp;produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of&nbsp;<em>C. difficile</em>&nbsp;cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhoea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</p><p>In patients with severe renal impairment (GFR &lt; 10 ml/min) a 33% increase in systemic exposure to azithromycin was observed (see section 5.2).</p><p>Prolonged cardiac repolarisation and QT interval, imparting a risk of developing cardiac arrhythmia and torsades de pointes, have been seen in treatment with other macrolides, including azithromycin (see section 4.8). Therefore as the following situations may lead to an increased risk for ventricular arrhythmias (including torsade de pointes) which can lead to cardiac arrest, azithromycin should be used with caution in patients with ongoing proarrhythmic conditions (especially women and elderly patients) such as patients: - With congenital or documented acquired QT prolongation.</p><p>- Currently receiving treatment with other active substances known to prolong QT interval such as antiarrhythmics of class IA (quinidine and procainamide) and class III (dofetilide, amiodarone and sotalol), cisapride and terfenadine; antipsychotic agents such as pimozide; antidepressants such as citalopram; and fluoroquinolones such as moxifloxacin and levofloxacin.</p><p>- With electrolyte disturbance, particularly in cases of hypokalaemia and hypomagnesaemia</p><p>- With clinically relevant bradycardia, cardiac arrhythmia or severe cardiac insufficiency.</p><p>Exacerbations of the symptoms of myasthenia gravis and new onset of myasthenia syndrome have been reported in patients receiving azithromycin therapy (see section 4.8).</p><p>Safety and efficacy for the prevention or treatment of&nbsp;<em>Mycobacterium Avium</em>&nbsp;Complex (MAC) in children have not been established.</p><p><strong>The following should be considered before prescribing azithromycin:</strong></p><p>Azithromycin is not suitable for treatment of severe infections where a high concentration of the antibiotic in the blood is rapidly needed.</p><p>The selection of azithromycin to treat an individual patient should take into account the appropriateness of using a macrolide antibacterial agent based on adequate diagnosis to ascertain the bacterial etiology of the infection in the approved indications and the prevalence of resistance to azithromycin or other macrolides.</p><p>In areas with a high incidence of erythromycin A resistance, it is especially important to take into consideration the evolution of the pattern of susceptibility to azithromycin and other antibiotics.</p><p>As for other macrolides, high resistance rates of Streptococcus pneumoniae have been reported for azithromycin in some European countries (see section 5.1). This should be taken into account when treating infections caused by Streptococcus pneumoniae.</p><p>In bacterial pharyngitis the use of azithromycin is recommended only in cases where first line therapy with beta-lactams is not possible.</p><p><em>Skin and soft tissue infections</em></p><p>The main causative agent of soft tissue infections,&nbsp;<em>Staphylococcus aureus</em>, is frequently resistant to azithromycin. Therefore, susceptibility testing is considered a precondition for treatment of soft tissue infections with azithromycin.</p><p><em>Infected burn wounds:</em></p><p>Azithromycin is not indicated for the treatment of infected burn wounds.</p><p><em>Sexually transmitted disease:</em></p><p>In case of sexually transmitted diseases a concomitant infection by&nbsp;<em>T. pallidium</em>&nbsp;should be excluded.</p><p><em>Neurological or psychiatric diseases:</em></p><p>Azithromycin should be used with caution in patients with neurological or psychiatric disorders.</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose- galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Antacids: </strong>In a pharmacokinetic study investigating the effects of simultaneous administration of antacids with azithromycin, no effect on overall bioavailability was seen, although peak serum levels were reduced by approximately 25%. Azithromycin must be taken at least 1 hour before or 2 hours after antacids.</p><p><strong><em>Cetirizine:</em></strong><strong> </strong>In healthy volunteers, coadministration of a 5-day regimen of azithromycin with cetirizine 20 mg at steady-state resulted in no pharmacokinetic interaction and no significant changes in the QT interval.</p><p><strong><em>Didanosins&nbsp;(Dideoxyinosine):</em></strong><em>&nbsp;</em>Coadministration of 1200 mg/day azithromycin with 400 mg/day didanosine in 6 HIV-positive subjects did not appear to affect the steady-state pharmacokinetics of didanosine as compared with placebo.</p><p><strong><em>Digoxin (P-gp substrates):</em></strong><strong> </strong>Concomitant administration of macrolide antibiotics, including azithromycin, with P-glycoprotein substrates such as digoxin, has been reported to result in increased serum levels of the P-glycoprotein substrate. Therefore, if azithromycin and P-gp substrates such as digoxin are administered concomitantly, the possibility of elevated serum concentrations of the substrate should be considered<em>.</em></p><p><strong><em>Zidovudine:</em></strong><strong> </strong>Single 1000 mg doses and multiple doses of 600 mg or 1200 mg azithromycin had little effect on the plasma pharmacokinetics or urinary excretion of zidovudine or its glucuronide metabolite. However, administration of azithromycin increased the concentrations of phosphorylated zidovudine, the clinically active metabolite, in peripheral blood mononuclear cells. The clinical significance of this finding is unclear, but it may be of benefit to patients.</p><p>Azithromycin does not interact significantly with the hepatic cytochrome P450 system. It is not believed to undergo the pharmacokinetic drug interactions as seen with erythromycin and other macrolides. Hepatic cytochrome P450 induction or inactivation via cytochrome-metabolite complex does not occur with azithromycin.</p><p><strong><em>Ergotamine derivatives:</em></strong><em>&nbsp;</em>Due to the theoretical possibility of ergotism, the concurrent use of azithromycin with ergot derivatives is not recommended (see section 4.4).</p><p>Pharmacokinetic studies have been conducted between azithromycin and the following drugs known to undergo significant cytochrome P450 mediated metabolism.</p><p><strong><em>Astemizole, alfentanil</em></strong><strong> </strong>There are no known data on interactions with astemizole or alfentanil. Caution is advised in the co-administration of these medicines with Azithromycin because of the known enhancing effect of these medicines when used concurrently with the macrolid antibiotic erythromycin.</p><p><strong><em>Atorvastatin:</em></strong><em>&nbsp;</em>Coadministration of atorvastatin (10 mg daily) and azithromycin (500 mg daily) did not alter the plasma concentrations of atorvastatin (based on a HMG CoA-reductase-inhibition assay). However, post-marketing cases of rhabdomyolysis in patients receiving azithromycin with statins have been reported.</p><p><strong><em>Carbamazepine:</em></strong><em>&nbsp;</em>In a pharmacokinetic interaction study in healthy volunteers, no significant effect was observed on the plasma levels of carbamazepine or its active metabolite in patients receiving concomitant azithromycin.</p><p><strong><em>Cisapride</em></strong><strong>: </strong>Cisapride is metabolized in the liver by the enzyme CYP 3A4. Because macrolides inhibit this enzyme, concomitant administration of cisapride may cause the increase of QT interval prolongation, ventricular arrhythmias and torsades de pointes.</p><p><strong><em>Cimetidine:</em></strong><em>&nbsp;</em>In a pharmacokinetic study investigating the effects of a single dose of cimetidine, given 2 hours before azithromycin, on the pharmacokinetics of azithromycin, no alteration of azithromycin pharmacokinetics was seen.</p><p><strong><em>Coumarin-Type Oral Anticoagulants:</em></strong><em>&nbsp;</em>In a pharmacokinetic interaction study, azithromycin did not alter the anticoagulant effect of a single 15-mg dose of warfarin administered to healthy volunteers. There have been reports received in the post-marketing period of potentiated anticoagulation subsequent to coadministration of azithromycin and coumarintype oral anticoagulants. Although a causal relationship has not been established, consideration should be given to the frequency of monitoring prothrombin time when azithromycin is used in patients receiving coumarin-type oral anticoagulants.</p><p><strong><em>Cyclosporin:</em></strong><em>&nbsp;</em>In a pharmacokinetic study with healthy volunteers that were administered a 500 mg/day oral dose of azithromycin for 3 days and were then administered a single 10 mg/kg oral dose of cyclosporin, the resulting cyclosporin C<sub>max</sub>&nbsp;and AUC<sub>0-5&nbsp;</sub>were found to be significantly elevated. Consequently, caution should be exercised before considering concurrent administration of these drugs. If coadministration of these drugs is necessary, cyclosporin levels should be monitored and the dose adjusted accordingly.</p><p><em>Efavirenz:&nbsp;</em>Coadministration of a 600 mg single dose of azithromycin and 400 mg efavirenz daily for 7 days did not result in any clinically significant pharmacokinetic interactions.</p><p><strong><em>Fluconazole:</em></strong><em>&nbsp;</em>Coadministration of a single dose of 1200 mg azithromycin did not alter the pharmacokinetics of a single dose of 800 mg fluconazole. Total exposure and half-life of azithromycin were unchanged by the coadministration of fluconazole, however, a clinically insignificant decrease in Cmax (18%) of azithromycin was observed.</p><p><strong><em>Indinavir:</em></strong>&nbsp;Coadministration of a single dose of 1200 mg azithromycin had no statistically significant effect on the pharmacokinetics of indinavir administered as 800 mg three times daily for 5 days.</p><p><strong><em>Methylprednisolone:</em></strong>&nbsp;In a pharmacokinetic interaction study in healthy volunteers, azithromycin had no significant effect on the pharmacokinetics of methylprednisolone.</p><p><strong><em>Midazolam:</em></strong>&nbsp;In healthy volunteers, coadministration of azithromycin 500 mg/day for 3 days did not cause clinically significant changes in the pharmacokinetics and pharmacodynamics of a single 15 mg dose of midazolam.</p><p><strong><em>Nelfinavir:</em></strong>&nbsp;Coadministration of azithromycin (1200 mg) and nelfinavir at steady state (750 mg three times daily) resulted in increased azithromycin concentrations. No clinically significant adverse effects were observed and no dose adjustment is required.</p><p><strong><em>Rifabutin:</em></strong>&nbsp;Coadministration of azithromycin and rifabutin did not affect the serum concentrations of either drug.</p><p>Neutropenia was observed in subjects receiving concomitant treatment of azithromycin and rifabutin. Although neutropenia has been associated with the use of rifabutin, a causal relationship to combination with azithromycin has not been established (see section 4.8).</p><p><strong><em>Sildenafil:</em></strong>&nbsp;In normal healthy male volunteers, there was no evidence of an effect of azithromycin (500 mg daily for 3 days) on the AUC and C<sub>max</sub>&nbsp;of sildenafil or its major circulating metabolite.</p><p><strong><em>Terfenadine:</em></strong>&nbsp;Pharmacokinetic studies have reported no evidence of an interaction between azithromycin and terfenadine. There have been rare cases reported where the possibility of such an interaction could not be entirely excluded; however there was no specific evidence that such an interaction had occurred.</p><p><strong><em>Theophylline:</em></strong><em>&nbsp;</em>There is no evidence of a clinically significant pharmacokinetic interaction when azithromycin and theophylline are co-administered to healthy volunteers. As interactions of other macrolides with theophylline have been reported, alertness to signs that indicate a rise in theophylline levels is advised.</p><p><strong><em>Triazolam:</em></strong>&nbsp;In 14 healthy volunteers, coadministration of azithromycin 500 mg on Day 1 and 250 mg on Day 2 with 0.125 mg triazolam on Day 2 had no significant effect on any of the pharmacokinetic variables for triazolam compared to triazolam and placebo.</p><p><strong><em>Trimethoprim/sulfamethoxazole:</em></strong>&nbsp;Coadministration of trimethoprim/sulfamethoxazole DS (160 mg/800 mg) for 7 days with azithromycin 1200 mg on Day 7 had no significant effect on peak concentrations, total exposure or urinary excretion of either trimethoprim or sulfamethoxazole. Azithromycin serum concentrations were similar to those seen in other studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Pregnancy</u></em></strong></p><p>There are no adequate data from the use of azithromycin in pregnant women. In reproduction toxicity studies in animals azithromycin was shown to pass the placenta, but no teratogenic effects were observed (see section 5.3). The safety of azithromycin has not been confirmed with regard to the use of the active substance during pregnancy. Therefore Azithromycin should only be used during pregnancy if the benefit outweighs the risk.</p><p><strong><em><u>Breast-feeding</u></em></strong></p><p>Azithromycin has been reported to be secreted into human breast milk, but there are no adequate and well-controlled clinical studies in nursing women that have characterized the pharmacokinetics of azithromycin excretion into human breast milk.</p><p>Because it is not known whether azithromycin may have adverse effects on the breast-fed infant, nursing should be discontinued during treatment with Azithromycin. Among other things diarrhoea, fungus infection of the mucous membrane as well as sensitisation is possible in the nursed infant. It is recommended to discard the milk during treatment and up until 2 days after discontinuation of treatment. Nursing may be resumed thereafter.</p><p><strong><em><u>Fertility</u></em></strong></p><p>In fertility studies conducted in rat, reduced pregnancy rates were noted following administration of azithromycin. The relevance of this finding to humans is unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No data are available regarding the influence of azithromycin on a patient&#39;s ability to drive or operate machinery.</p><p>However, the possibility of undesirable effects like dizziness and convulsions should be taken into account when performing these activities.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The table below lists the adverse reactions identified through clinical trial experience and post-marketing surveillance by system organ class and frequency. Adverse reactions identified from post-marketing experience are included in italics. The frequency grouping is defined using the following convention: Very common (&ge;1/10); Common (&ge; 1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare (&ge; 1/10,000 to &lt;1/1,000); Very Rare (&lt; 1/10,000); and Not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p><strong>Adverse reactions possibly or probably related to azithromycin based on clinical trial experience and post-marketing surveillance:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:670px"><tbody><tr><td style="vertical-align:top"><p><strong>very common</strong></p><p>&ge; 1/10</p></td><td style="vertical-align:top"><p><strong>common</strong></p><p>&ge; 1/100 to &lt; 1/10</p></td><td style="vertical-align:top"><p><strong>uncommon</strong></p><p>&ge; 1/1,000 to &lt; 1/100</p></td><td style="vertical-align:top"><p><strong>rare</strong></p><p>&ge; 1/10,000 to &lt;1/1,000</p></td><td style="vertical-align:top"><p><strong>very rare</strong></p><p>&lt; 1/10,000</p></td><td style="vertical-align:top"><p><strong>not known</strong></p><p>frequency cannot be estimated from available data</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Infections and infestations</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Candidiasis, oral, candidiasis, vaginal infection, pneumonia, fungal infection, bacterial infection, pharyngitis, gastroenteritis, respiratory disorder, rhinitis.</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Pseudomembranous colitis (see section 4.4)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Leukopenia, neutropenia, eosinophilia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Thrombocytopenia, haemolytic anaemia</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Angioedema</p><p>hypersensitivity</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic reaction (see section 4.4.)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Nervousness, insomnia</p></td><td style="vertical-align:top"><p>Agitation, depersonalisation</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Aggression</p><p>anxiety, delirium, hallucination</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dizziness, headache, paraesthesia, dysgeusia</p></td><td style="vertical-align:top"><p>Hypoaesthesia</p><p>somnolence</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Syncope, convulsion, psychomotor hyperactivity, anosmia, ageusia, parosmia, Myasthenia gravis</p><p>(see section 4.4)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Visual impairment</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Deafness</p></td><td style="vertical-align:top"><p>Ear disorder, vertigo, hearing impaired, tinnitus</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Palpitations</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Torsades de pointes (see section 4.4)</p><p>arrhythmia (see section 4.4) including ventricular tachycardia.</p><p>Electrodiogram QT prolonged (see section 4.4)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hot flush</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypotension</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dyspnoea, epistaxis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea, abdominal pain, nausea, flatulence</p></td><td style="vertical-align:top"><p>Vomiting, dyspepsia</p></td><td style="vertical-align:top"><p>Gastritis, constipation, dysphagia, abdominal distension, dry mouth, eructation, mouth ulceration, salivary hypersecretion</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Pancreatitis, tongue and teeth discoloration</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Hepatobiliary&nbsp;disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hepatitis,</p></td><td style="vertical-align:top"><p>Hepatic function abnormal, jaundice cholestatic</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hepatic failure (which has rarely resulted in death) (see section 4.4)*, hepatitis fulminant, hepatic necrosis,</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash, pruritus</p></td><td style="vertical-align:top"><p>Stevens-Johnson syndrome, photosensitivity reaction, urticaria, Dermatitis, dry skin, hyperhidrosis</p></td><td style="vertical-align:top"><p>Allergic reactions including angioneurotic oedema</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Toxic epidermal necrolysis, erythema multiforme,</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Musculoskeletal and connective tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Osteoarthritis, Myalgia, back pain, neck pain</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dysuria, renal pain</p></td><td style="vertical-align:top"><p>Renal failure acute, nephritis interstitial</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Metrorrhagia, testicular disorder</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Fatigue</p></td><td style="vertical-align:top"><p>Chest pain, face oedema, pyrexia, peripharal pain, oedema</p><p>malaise</p><p>asthenia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Investigations</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Lymphocyte count decreased, eosinophil count increased, blood bicarbonate decreased, basophils increased, monocytes increased, neutrophils increased</p></td><td style="vertical-align:top"><p>Aspartate aminotransferase increased, alanine aminotransferase increased, blood bilirubin increased, blood urea increased, blood creatinine increased, blood potassium abnormal, blood alkaline phosphatase increased, chloride increased, glucose increased, platelets increased, hematocrit decreased, bicarbonate increased, abnormal sodium</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p><strong>Injury and poisoning</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Post procedural complications</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>Adverse reactions possibly or probably related to&nbsp;<em>Mycobacterium Avium</em>&nbsp;Complex prophylaxis and treatment based on clinical trial experience and post-marketing surveillance. These adverse reactions differ from those reported with immediate release or the prolonged release formulations, either in kind or in frequency:</p><table border="1" cellspacing="0" cellpadding="0" style="width:670px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Nervous System Disorders</strong></p></td><td style="vertical-align:top"><p>Dizziness, headache, paraesthesia, dysgeusia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Hypoesthesia</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye Disorders</strong></p></td><td style="vertical-align:top"><p>Visual impairment</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Ear and Labyrinth Disorders</strong></p></td><td style="vertical-align:top"><p>Deafness</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Hearing impaired, tinnitus</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td><td style="vertical-align:top"><p>Palpitations</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td><td style="vertical-align:top"><p>Diarrhoea, abdominal pain, nausea, flatulence, abdominal discomfort, loose stools</p></td><td style="vertical-align:top"><p>Very common</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary&nbsp;Disorders</strong></p></td><td style="vertical-align:top"><p>Hepatitis</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Skin and Subcutaneous Tissue Disorders</strong></p></td><td style="vertical-align:top"><p>Rash, pruritus</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Steven-Johnson syndrome, photosensitivity reaction</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>General Disorders and Administration Site Conditions</strong></p></td><td style="vertical-align:top"><p>Fatigue</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Asthenia, malaise</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr></tbody></table><p>&nbsp;</p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>:</u></em></strong><strong><em><u> </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events experienced in higher than recommended doses were similar to those seen at normal doses.</p><p><strong><em>Symptoms</em></strong></p><p>The typical symptoms of an overdose with macrolide antibiotics include reversible loss of hearing, severe nausea, vomiting and diarrhoea.</p><p><strong><em>Treatment</em></strong></p><p>In the event of overdose, general symptomatic and supportive measures are indicated as required.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Antibacterials for systemic use, macrolides. ATC code: J01FA10.</p><p>Azithromycin is a macrolide antibiotic belonging to the azalide group.</p><p>The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The chemical name of azithromycin is 9-deoxy-9a-aza-9a-methyl-9a-homoerythromycin A. The molecular weight is 749.0.</p><p><strong><em>Mode of action</em></strong></p><p>Azithromycin is an azalide, a sub-class of the macrolide antibiotics. By binding to the 50Sribosomal sub-unit, azithromycin avoids the translocation of peptide chains from one side ofthe ribosome to the other. As a consequence of this, RNA-dependent protein synthesis in sensitive organisms is prevented.</p><p><strong><em>PK/PD relationship:</em></strong></p><p>For azithromycin the AUC/MIC is the major PK/PD parameter correlating best with the efficacy of azithromycin.</p><p><strong><em>Mechanism of resistance:</em></strong></p><p>Resistance to azithromycin may be inherent or acquired. There are three main mechanisms of resistance in bacteria: target site alteration, alteration in antibiotic transport and modification of the antibiotic.</p><p>Complete cross resistance exists among&nbsp;<em>Streptococcus pneumoniae</em>, betahaemolytic streptococcus of group A,<em>Enterococcus faecalis</em>&nbsp;and&nbsp;<em>Staphylococcus aureus</em>, including methicillin resistant&nbsp;<em>S. aureus</em>&nbsp;(MRSA) to erythromycin, azithromycin, other macrolides and lincosamides.</p><p><strong>Breakpoints</strong></p><p>EUCAST (European Committee on Antimicrobial Susceptibility Testing)</p><table border="1" cellspacing="0" cellpadding="0" style="width:667px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p><strong>MIC breakpoint (mg/L)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Pathogens</strong></p></td><td style="vertical-align:top"><p><strong>Susceptible (mg/L)</strong></p></td><td style="vertical-align:top"><p><strong>Resistant (mg/L)</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus spp.</em></p></td><td style="vertical-align:top"><p>&le; 1</p></td><td style="vertical-align:top"><p>&gt; 2</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus spp.</em>&nbsp;(Group A, B, C, G)</p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>&gt; 0.5</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>&gt; 0.5</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus&nbsp;influenzae</em></p></td><td style="vertical-align:top"><p>&le; 0.125</p></td><td style="vertical-align:top"><p>&gt; 4</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>&gt; 0.5</p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria gonorrhoeae</em></p></td><td style="vertical-align:top"><p>&le; 0.25</p></td><td style="vertical-align:top"><p>&gt; 0.5</p></td></tr></tbody></table><p><strong>Susceptibility:</strong></p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p>Pathogens for which resistance may be a problem: prevalence of resistance is equal to or greater than 10% in at least one country in the European Union.</p><p>Table of susceptibility</p><table border="1" cellspacing="0" cellpadding="0" style="width:663px"><tbody><tr><td style="vertical-align:top"><p><strong>Commonly susceptible species.</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobic Gram-negative microorganisms</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus&nbsp;influenzae*</em></p><p><em>Moraxella catarrhalis*</em></p><p>Other microorganisms</p><p><em>Chlamydophila&nbsp;pneumoniae</em></p><p><em>Chlamydia trachomatis</em></p><p><em>Legionella pneumophila</em></p><p><em>Mycobacterium avium</em></p><p><em>Mycoplasma pneumonia*</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p>Aerobic Gram-positive microorganisms</p><p><em>Staphylococcus aureus*</em></p><p><em>Streptococcus agalactiae</em></p><p><em>Streptococcus pneumoniae*</em></p><p><em>Streptococcus pyogenes*</em></p><p>Other microorganisms</p><p><em>Ureaplasma urealyticum</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms</strong></p></td></tr><tr><td style="vertical-align:top"><p>Aerobic Gram-positive microorganisms</p><p><em>Staphylococcus aureus &ndash; methicillin resistant and erythromycin resistant strains</em></p><p><em>Streptococcus pneumoniae &ndash; penicillin resistant strains</em></p><p><em>Aerobic Gram-negative microorganisms</em></p><p><em>Escherichia coli</em></p><p><em>Pseudomonas aeruginosa</em></p><p><em>Klebsiella&nbsp;spp.</em></p><p>Anaerobic Gram-negative microorganisms</p><p><em>Bacteroides&nbsp;fragilis-group</em></p></td></tr></tbody></table><p>* Clinical effectiveness is demonstrated by sensitive isolated organisms for approved clinical indications.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Absorption:</u></em></strong></p><p>Bioavailability of azithromycin after oral administration is approximately 37%. Peak plasma concentrations are attained after 2-3 hours. The mean maximum concentration observed (C<sub>max</sub>) after a single dose of 500 mg is approximately 0.4 &mu;g/ml.</p><p><strong><em><u>Distribution:</u></em></strong></p><p>Orally administered azithromycin is widely distributed throughout the body.</p><p>Pharmacokinetic studies have demonstrated that the concentrations of azithromycin measured in tissues are noticeably higher (up to 50 times the maximum observed concentration in plasma) than those measured in plasma. This indicates that the agent strongly binds to tissues (steady-state distribution volume approx. 31 l/kg).</p><p>At the recommended dose no accumulation appears in the serum. Accumulation appears in tissues where levels are much higher than in serum. Three days after administration of 500 mg as a single dose or in partial doses concentrations of 1,3-4,8 &mu;g/g, 0,6-2,3 &mu;g/g, 2,0-2,8 &mu;g/g and 0-0,3 &mu;g/ml have been measured in resp. lung, prostate, tonsil and serum.</p><p>In experimental&nbsp;<em>in vitro&nbsp;</em>and&nbsp;<em>in vivo</em>&nbsp;studies azithromycin accumulates in phagocytes. Release is stimulated by active phagocytosis. In animal models this process contributes to the accumulation of azithromycin in tissue.</p><p>Binding of azithromycin to serum proteins is variable and varies from 52% at 0,05 mg/l to 18% at 0,5 mg/l, depending on the serum concentration.</p><p><strong><u>Excretion:</u></strong></p><p>The terminal plasma elimination half-life closely reflects the elimination half-life from tissues of 2-4 days.</p><p>Approximately 12% of an intravenously administered dose is excreted in unchanged form with the urine over a period of 3 days; the major proportion in the first 24 hours. Concentrations of up to 237 &mu;g/ml azithromycin, 2 days after a 5-day course of treatment, have been found in human bile. Ten metabolites have been identified (formed by N- and O-demethylation, by hydroxylation of the desosamine and aglycone rings, and by splitting of the cladinose conjugate). Investigations suggest that the metabolites do not play a role in the microbiological activity of azithromycin.</p><p><strong><u>Pharmacokinetics in Special populations:</u></strong></p><p><strong><em>Renal Insufficiency:</em></strong></p><p>Following a single oral dose of azithromycin 1 g, mean C<sub>max</sub>&nbsp;and AUC<sub>0-120</sub>&nbsp;increased by 5.1% and 4.2% respectively, in subjects with mild to moderate renal impairment (glomerular filtration rate of 10-80 ml/min) compared with normal renal function (GFR &gt; 80ml/min). In subjects with severe renal impairment, the mean C<sub>max</sub>&nbsp;and AUC<sub>0-120</sub>&nbsp;increased 61% and 35% respectively compared to normal.</p><p><strong><em>Hepatic insufficiency:</em></strong></p><p>In patients with mild to moderate hepatic impairment, there is no evidence of a marked change in serum pharmacokinetics of azithromycin compared to normal hepatic function. In these patients, urinary recovery of azithromycin appears to increase perhaps to compensate for reduced hepatic clearance.</p><p><strong><em>Elderly:</em></strong></p><p>The pharmacokinetics of azithromycin in elderly men was similar to that of young adults; however, in elderly women, although higher peak concentrations (increased by 30-50%) were observed, no significant accumulation occurred.</p><p>In elderly volunteers (&gt; 65 years) higher (29%) AUC values have been measured after a 5 day treatment than in younger volunteers (&lt; 45 years). These differences are not regarded as clinically relevant; dose adjustment is therefore not recommended.</p><p><strong><em>Infants, toddlers, children and adolescents:</em></strong></p><p>Pharmacokinetics has been studied in children aged 4 months &ndash; 15 years taking capsules, granules or suspension. At 10 mg/kg on day 1 followed by 5 mg/kg on days 2-5, the C<sub>max</sub>&nbsp;achieved is slightly lower than in adults, with 224 &micro;g/l in children aged 0.6-5 years and after 3 days dosing, and 383 &micro;g/l in those aged 6-15 years. The half-life of 36 h in the older children was within the expected range for adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In animal studies using exposures 40 times those achieved at the clinical therapeutic dosages, azithromycin was found to have caused reversible phospholipidosis, but as a rule there were no associated toxicological consequences. The relevance of this finding to humans receiving azithromycin in accordance with the recommendations is unknown.</p><p>Electrophysiological investigations have shown that azithromycin prolongs the QT interval.</p><p><strong><em>Carcinogenic potential:</em></strong></p><p>Long-term studies in animals have not been performed to evaluate carcinogenic potential.</p><p><strong><em>Mutagenic potential:</em></strong></p><p>There was no evidence of a potential for genetic and chromosome mutations in&nbsp;<em>in-vivo</em>&nbsp;and&nbsp;<em>in-vitro</em>&nbsp;test models.</p><p><strong><em>Reproductive toxicity:</em></strong></p><p>Teratogenic effects were not observed in rat reproductive toxicity studies. In rats, azithromycin dosages of 100 and 200 mg/kg bodyweight/ day led to mild retardation in foetal ossification and in maternal weight gain. In peri- and postnatal studies in rats mild retardations in physical and reflex development were noted following treatment with 50 mg/kg/day azithromycin and above.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:653px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><ol><li>Maize starch</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Sodium lauryl sulphate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Magnesium stearate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Lactose anhydrous</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Empty hard gelatin capsule shell size &ldquo;0&rdquo;</li></ol></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                48 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C, in a dry place</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>6 capsules in a blister, packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street,
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                19. November. 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>